RecruitingNot ApplicableNCT04421846

Study of Pathophysiology of Status Epilepticus and Dysimmune Encephalitis

COLETTE : Study of the Pathophysiology of Status Epilepticus and Dysimmune Encephalitis and Identification of Valuable Biomarkers

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

400 participants

Start Date

Nov 25, 2020

Study Type

INTERVENTIONAL

Conditions

Status Epilepticus Dysimmune Encephalopathy

Summary

COLETTE is an interventional study for which blood, cerebrospinal fluid and post-mortem tissues are collected in patients with status epilepticus or epilepsy associated to dysimmune encephalitis as well as in control patients, to better understand the pathophysiology of these severe epileptic disorders.

Eligibility

Min Age: 2 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Blood sampling, cerebrospinal fluid , post-mortem cerebral tissues (NA for the Group 3) and Blood sampling, cerebrospinal fluid, stool sampling post-mortem cerebral tissues (NA for the Group 3) for people with dysimmune encephalopathy and status epilepticus. The study is currently recruiting participants at 1 location. People eligible for this study include aged 2 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.